Retaglutide is a innovative GLP-1 receptor agonist currently under research for the control of obesity. This drug works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone that https://rebeccabkhd685182.dbblog.net/12154933/trelaglutide-exploring-a-new-option-for-chronic-diseases